drugset

Drugs / D150

Follow last change Nov 2025 re-read 2 minutes ago

D150

Investigated by: Chong Kun Dang Pharmaceutical

Trials 16 · a red edge is where a trial was stopped

today NCT07304726 · Ph 1 NCT07304700 · Ph 1 NCT07304687 · Ph 1 NCT05897216 · Ph 1 NCT05928637 · Ph 1 NCT05952219 · Ph 1 NCT05816759 · Ph 1 NCT05741437 · Ph 1 NCT05719155 · Ph 1 NCT05452525 · Ph 1 NCT05347576 · Ph 1 NCT04810676 · Ph 1 NCT04706286 · Ph 1 NCT04431687 · Ph 1 NCT04334213 · Ph 1 NCT04260438 · Ph 1

202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 116 trials
Phase 1	NCT07304726	Oct → Nov 2025	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT07304700	Oct → Nov 2025	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT07304687	Oct → Nov 2025	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT05897216	Jul 2023	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT05928637	Jul → Aug 2023	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT05952219	Jun 2023	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Unknown	No outcome recorded
Phase 1	NCT05816759	May → Jun 2023	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT05741437	Apr → Aug 2023	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT05719155	Feb → Mar 2023	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT05452525	Jul → Aug 2022	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT05347576	Apr → May 2022	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT04810676	Apr → May 2021	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT04706286	Feb → Mar 2021	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Unknown	No outcome recorded
Phase 1	NCT04431687	Jun → Jul 2020	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT04334213	May → Aug 2020	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded
Phase 1	NCT04260438	Apr → Jun 2020	type 2 diabetes mellitus	Chong Kun Dang Pharmaceutical	Completed	No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 16 sources stand behind the page.

Field	Value	Cited text
Known as	D150	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05816759 ↗ 15 NCT05952219 ↗ NCT04334213 ↗ NCT07304700 ↗ NCT05897216 ↗ NCT05347576 ↗ NCT04431687 ↗ NCT07304726 ↗ NCT05452525 ↗ NCT07304687 ↗ NCT04260438 ↗ NCT05719155 ↗ NCT04810676 ↗ NCT05741437 ↗ NCT04706286 ↗ NCT05928637 ↗
Route	Oral	“single oral administration under fed condition” NCT04260438 ↗